Improving reporting of adverse events and adverse drug reactions following injections of Chinese materia medica

Journal of Evidence-Based Medicine

Volumn 3, Issue 1, 2010, Pages 5-10

  Bian, Zhao Xiang ^a   Tian, Hao Yao ^a   Gao, Lin ^a   Shang, Hong Cai ^b   Wu, Tai Xiang ^c   Li, You Ping ^c   Zhang, Bo Li ^b   Song, Li ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c Chinese Cochrane Center   (China)

Author keywords

Adverse drug reactions; Adverse events; Injection of Chinese material medica; Quality; Reporting

Indexed keywords

CHINESE DRUG;

ALLERGY; ARTICLE; CASE REPORT; CHINESE MEDICINE; DATA BASE; DEMOGRAPHY; DRUG EFFECT; DRUG INDUSTRY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT INDICATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; FEMALE; HUMANS; MALE; MATERIA MEDICA; MEDICINE, CHINESE TRADITIONAL; QUALITY CONTROL;

EID: 77954573495     PISSN: 17565383     EISSN: 17565391     Source Type: Journal    
DOI: 10.1111/j.1756-5391.2010.01055.x     Document Type: Article

References (13)

1. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis and management. Lancet 2000; 356(9237): 1255-1259.
2. Cornelius VR, Perrio MJ, Shakir SA, Smith LA. Systematic reviews of adverse effects of drug interventions: a survey of their conduct and reporting quality. Pharmacoepidemiology and Drug Safety 2009; 18(12): 1223-1231.
3. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274: 29-34.
4. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. The New England Journal of Medicine 2003; 348: 1556-1564.
5. Pitrou I, Boutron I, Ahmad N, Ravaud P. Reporting of safety results in published reports of randomized controlled trials. Archives of Internal Medicine 2009; 169(19): 1756-1761.
6. Aronson JK. Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions. Drug Safety 2008; 31(4): 355-356.
7. Luo YX, Zhang YF. Analysis about adverse drug reaction induced by concomitant use of Chinese meteria medica injection and western medicine injection. Journal of Sino-Western Medical Therapy 2009; 23: 153-154.
8. Wang J, Jian Y, Huang PC. 228 cases reports about ADR of Herba Houttuyniae injection. Journal of Business Information of Medical Product 2006; 3(17): 191-192.
9. http://www.hljda.gov.cn/show.aspx?newsid=2820&typeid=25 (accessed as at 24 Nov 2009).
10. Zhou X, Guang XJ. Review about Chinese material medica injection license approval and adverse drug reaction. Shanghai Medical & Pharmaceutical Journal 2009; 30(8): 363-364.
11. Zhang Q, Jin C, XIAO XH, Wu YS, Yan D, Yin RL. Probe of early prediction methods for adverse drug reaction and quality fluctuation in Chinese materia medica injection. Chinese traditional and Herbal Drugs 2009; 40(3): 337-40, 373.
12. Wu TX, Li YP, Bian ZX, Chen KJ, Zhang BL, Shang HC, Moher D. Practice good publication practice to improve the transparence of clinical trials. Chinese Journal of Evidence Based Medicine 2007; 7(8): 551-554.
13. Wu TX, Li YP, Bian ZX, Li TJ, Li J, Dagenais S, Moher D;for CONOSRT for TCM Working Group. Consolidated Standards for reporting trials of Traditional Chinese Medicine (CONSORT for TCM). Chinese Journal of Evidence Based Medicine 2007; 7(8): 601-605.